Literature DB >> 14599787

Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques.

Dalma Vödrös1, Rigmor Thorstensson, Robert W Doms, Eva Maria Fenyö, Jacqueline D Reeves.   

Abstract

Coreceptor use of HIV can evolve during infection. We previously examined coreceptor use of related SIVsm inoculum viruses and sequential reisolates from cynomolgus macaques. These viruses exhibited broad coreceptor specificities and, generally, CCR5 use remained efficient and stable, while alternative coreceptor use decreased longitudinally. Here we demonstrate that individual envelopes (Envs) from inoculum and reisolate viruses fuse via a range of coreceptors, including CCR5, CCR8, CXCR6, GPR15, GPR1, and APJ. On the whole, coreceptor use of Envs from sequential reisolates recapitulated that of reisolate viruses, thus CCR5 use remained stable while alternative coreceptor use tended to decrease over time. Rhesus CCR5, GPR15, and CXCR6 supported fusion to a similar extent as their human counterparts. Additionally, a number of Envs mediated CD4-independent fusion via CCR5 and GPR15. Envs from different inoculum viruses exhibited distinct dependencies on CD4 for fusion via CCR5, ranging from strictly CD4-dependent to efficiently CD4-independent. Early reisolates from macaques infected with CD4-independent inoculums maintained or evolved Envs with a broad range of CD4-independence. CD4-independence became less variable/efficient in late reisolates from macaques that developed neutralizing antibodies. Infection with a CD4-dependent virus resulted in evolution of CD4-independent Envs in late reisolates. While CD4 independence can potentially broaden tropism in vivo, CD4-independent viruses are particularly sensitive to neutralizing antibodies. Therefore, interplay between receptor tropism and neutralization may shape viral evolution and SIV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599787     DOI: 10.1016/s0042-6822(03)00579-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Simian immunodeficiency virus envelope compartmentalizes in brain regions independent of neuropathology.

Authors:  Maria F Chen; Susan Westmoreland; Elena V Ryzhova; Julio Martín-García; Samantha S Soldan; Andrew Lackner; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

2.  Effects of stabilization of the gp41 cytoplasmic domain on fusion activity and infectivity of SIVmac239.

Authors:  Andrei N Vzorov; Richard W Compans
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-04       Impact factor: 2.205

3.  A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.

Authors:  A Bonavia; B T Bullock; K M Gisselman; B J Margulies; J E Clements
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

4.  Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.

Authors:  Adrienne E Swanstrom; Beth Haggarty; Andrea P O Jordan; Josephine Romano; George J Leslie; Pyone P Aye; Preston A Marx; Andrew A Lackner; Gregory Q Del Prete; James E Robinson; Michael R Betts; David C Montefiori; Celia C LaBranche; James A Hoxie
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

5.  Differential phosphorylation signals control endocytosis of GPR15.

Authors:  Yukari Okamoto; Sojin Shikano
Journal:  Mol Biol Cell       Date:  2017-06-14       Impact factor: 4.138

6.  Acquisition of CD4-dependence by CD4-independent SIV passaged in human peripheral blood mononuclear cells.

Authors:  Sujatha Iyengar; David H Schwartz
Journal:  Retrovirology       Date:  2012-07-25       Impact factor: 4.602

7.  Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host.

Authors:  L J Demma; T H Vanderford; J M Logsdon; M B Feinberg; S I Staprans
Journal:  Retrovirology       Date:  2006-03-20       Impact factor: 4.602

8.  CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.

Authors:  Anna Laurén; Elzbieta Vincic; Hiroo Hoshino; Rigmor Thorstensson; Eva Maria Fenyö
Journal:  Retrovirology       Date:  2007-07-23       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.